Using Twitter to Assess the Public Response to the United States Preventive Services Task Force Guidelines on Lung Cancer Screening with Low Dose Chest CT

Abstract Background Annual lung cancer screening (LCS) with low-dose chest computed tomography in older current and former smokers (ie, eligible adults) has been recommended since 2013. Uptake has been slow and variable across the United States. We estimated the LCS rate and growth at the national and state level between 2016 and 2018. Methods The American College of Radiology’s Lung Cancer Screening Registry was used to capture screening events. Population-based surveys, the US Census, and cancer registry data were used to estimate the number of eligible adults and lung cancer mortality (ie, burden). Lung cancer screening rates (SRs) in eligible adults and screening rate ratios with 95% confidence intervals (CI) were used to measure changes by state and year. Results Nationally, the SR was steady between 2016 (3.3%, 95% CI = 3.3% to 3.7%) and 2017 (3.4%, 95% CI = 3.4% to 3.9%), increasing to 5.0% (95% CI = 5.0% to 5.7%) in 2018 (2018 vs 2016 SR ratio = 1.52, 95% CI = 1.51 to 1.62). In 2018, several southern states with a high lung-cancer burden (eg, Mississippi, West Virginia, and Arkansas) had relatively low SRs (<4%) among eligible adults, whereas several northeastern states with lower lung cancer burden (eg, Massachusetts, Vermont, and New Hampshire) had the highest SRs (12.8%-15.2%). The exception was Kentucky, which had the nation’s highest lung cancer mortality rate and one of the highest SRs (13.7%). Conclusions Fewer than 1 in 20 eligible adults received LCS nationally, and uptake varied widely across states. LCS rates were not aligned with lung cancer burden across states, except for Kentucky, which has supported comprehensive efforts to implement LCS.

Download Full-text

The United States Preventive Services Task Force Recommendations for Lung Cancer Screening

Thoracic Surgery Clinics ◽

10.1016/j.thorsurg.2014.12.004 ◽

2015 ◽

Vol 25 (2) ◽

pp. 199-203 ◽

Cited By ~ 5

Author(s):

Shanda H. Blackmon ◽

Shamiram R. Feinglass

Keyword(s):

United States ◽

Lung Cancer ◽

Cancer Screening ◽

Task Force ◽

Preventive Services ◽

Lung Cancer Screening ◽

The United States

Download Full-text

A Proactive Patient Identification Algorithm Increased Low-Dose CT Lung Cancer Screening Eligible Patients Per United States Preventative Services Task Force Criteria

Journal of the American College of Surgeons ◽

10.1016/j.jamcollsurg.2021.07.238 ◽

2021 ◽

Vol 233 (5) ◽

pp. S123

Author(s):

Jared R. Hendren ◽

Sowmyanarayanan Thuppal ◽

Stephen Hazelrigg ◽

Rebecca Hoffman ◽

Amit Sapra ◽

...

Keyword(s):

United States ◽

Lung Cancer ◽

Cancer Screening ◽

Low Dose ◽

Task Force ◽

Lung Cancer Screening ◽

Identification Algorithm ◽

Patient Identification ◽

Low Dose Ct ◽

Preventative Services

Download Full-text

Evaluating efficacy of current lung cancer screening guidelines

Journal of Medical Screening ◽

10.1177/0969141316689111 ◽

2017 ◽

Vol 24 (4) ◽

pp. 208-213 ◽

Cited By ~ 3

Author(s):

Barbara Nemesure ◽

April Plank ◽

Lisa Reagan ◽

Denise Albano ◽

Michael Reiter ◽

...

Keyword(s):

United States ◽

Lung Cancer ◽

Cancer Screening ◽

National Comprehensive Cancer Network ◽

Task Force ◽

Preventive Services ◽

Lung Cancer Screening ◽

The United States ◽

Smoking History ◽

Cancer Network

Objective Current lung cancer screening criteria based primarily on outcomes from the National Lung Screening Trial may not adequately capture all subgroups of the population at risk. We aimed to evaluate the efficacy of lung cancer screening criteria recommended by the United States Preventive Services Task Force, Centers for Medicare and Medicaid Services, and the National Comprehensive Cancer Network in identifying known cases of lung cancer. Methods An investigation of the Stony Brook Cancer Center Lung Cancer Evaluation Center's database identified 1207 eligible, biopsy-proven lung cancer cases diagnosed between January 1996 and March 2016. Age at diagnosis, smoking history, and other known risk factors for lung cancer were used to determine the proportion of cases that would have met current United States Preventive Services Task Force, Centers for Medicare and Medicaid Services, and National Comprehensive Cancer Network eligibility requirements for lung cancer screening. Results Of the 1046 ever smokers in the study, 40% did not meet the National Lung Screening Trial age requirements, 20% did not have a ≥30 pack year smoking history, and approximately one-third quit smoking >15 years before diagnosis, thus deeming them ineligible for screening. Applying the United States Preventive Services Task Force, Centers for Medicare and Medicaid Services, and National Comprehensive Cancer Network eligibility criteria to the Stony Brook Cancer Center's Lung Cancer Evaluation Center cases, 49.2, 46.3, and 69.8%, respectively, would have met the current lung cancer screening guidelines. Conclusions The United States Preventive Services Task Force and Centers for Medicare and Medicaid Services eligibility criteria for lung cancer screening captured less than 50% of lung cancer cases in this investigation. These findings highlight the need to reevaluate the efficacy of current guidelines and may have major public health implications.

Download Full-text

Effectiveness of low-dose CT scan for lung cancer screening in the community setting.

Journal of Clinical Oncology ◽

10.1200/jco.2019.37.15_suppl.1543 ◽

2019 ◽

Vol 37 (15_suppl) ◽

pp. 1543-1543

Author(s):

Jason Aboudi Mouabbi ◽

Tarik H. Hadid ◽

Eugene Uh

Keyword(s):

Lung Cancer ◽

Cancer Screening ◽

High Risk ◽

Low Dose ◽

Task Force ◽

Demographic Data ◽

Community Setting ◽

Lung Cancer Screening ◽

Lung Cancer Mortality ◽

The United States

1543 Background: Lung cancer is the leading cause of cancer death in the United States (US) and worldwide. Chest X-ray (CXR) is ineffective in reducing lung cancer mortality. National Lung Cancer Screening Trail (NLST) reported 20% reduction in mortality with the use of low-dose computed tomography (LDCT) scan to screen high risk individuals. Therefore, major organizations including US Preventive Services Task Force has adopted LDCT for lung cancer screening in high risk populations. However, The generalizability of this approach in community setting is yet to be confirmed. Our objective is to assess the ability of LDCT in detection of lung nodules and lung cancer in the community setting and compare the results to those reported in the NLST. Methods: Charts of subjects who underwent LDCT screening between 2013 and 2016 at SJHMC were retrospectively reviewed. Demographic data, the results of the LDCT scans, interventions performed, complications of procedures and pathology findings were collected. All cancer cases found by LDCT and the stage of cancers were documented. The results of our study were statistically compared to the results of both arms of the NLST (CT and CXR arms). Since CXR is ineffective for lung cancer screening, CXR arm serves equivalently to no screening. Results: The baseline characteristics of the subjects are significantly different between this study and NLST. LDCT in our study detected significantly higher positive findings. There are more cancers detected in this study compared to NLST CT and CXR arms, which could reflect higher incidence of cancer in this community or higher proportion of current smokers in our study. In this study, LDCT detected cancers at higher stages compared to that of the NLST CT arm but similar stages to NLST CXR arm. This may indicate that LDCT when performed in the community is less effective in detecting cancer at early stages. Conclusions: The community population have different characteristics compared those enrolled in clinical trials. This may limit the generalizability of the results. Population-based studies are needed to confirm the results of the NLST. [Table: see text]

Download Full-text